Jeffrey A. Sosman
Northwestern University(US)Midwestern University(US)University Medical Center(US)Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityVanderbilt University Medical Center(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Improved Survival with Ipilimumab in Patients with Metastatic Melanoma(2010)15,037 cited
- → Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer(2012)12,531 cited
- → Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation(2011)7,653 cited
- → Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma(2015)5,840 cited
- → Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2017)5,338 cited
- → Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma(2007)3,641 cited
- →